The gray zone, defined as left ventricular hypertrophy of 1.3-1.5 cm in athletes, represents a significant diagnostic conundrum in sports cardiology with significant management and counseling ...

The following are key points to remember from a systematic review and meta-analysis on the effects of catheter-based renal denervation in patients with hypertension (HTN): ...

The following are key points to remember from a review on endovascular management of acute stroke: ...

Systolic BP is lowered by about 5 mm Hg in patients taking semaglutide for weight loss. The full antihypertensive effect of semaglutide may be greater, as patients often had their antihypertension ...

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based ...

In patients with ACS undergoing PCI with DES, 1 month of DAPT followed by potent P2Y12 inhibitor monotherapy was associated with a reduction in major bleeding without increasing MACCE when compared ...

In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and ...

While rates of recurrent rejection have declined in the current era, around 1 in 10 children post-heart transplant will experience recurrent rejection. Children who experience recurrent rejection are ...

See C, Mooghali M, Dhruva SS, Ross JS, Krumholz HM, Kadakia KT. There were 137 Class I recall events affecting 157 unique cardiovascular devices, of which 112 (71%) were moderate-risk 510(k) devices ...

The American College of Cardiology/Association of Black Cardiologists Merck Research Fellowships provide three one-year fellowships in the amount of $100,000 each to be awarded as salary support for ...

There are several companies that are not affiliated with the American College of Cardiology that are posting registration and housing information for ACC.24. To protect your information, please only ...

This page features ACC's full coverage of the latest science from Transcatheter Cardiovascular Therapeutics (TCT) 2024 – including trial summaries, news stories, journal scans, videos and more.